Talk:BPC-157
Appearance
![]() | This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||||||||||||||||||||||
|
BPC-157 has 4 human studies done or registered
[edit]The article claims no human studies, but BPC-157 has at least 4 human studies done in the past and/or registered/ongoing. Data is bloody difficult to find however.
I found e.g. these:
Veljaca M, Pavic-Sladoljev D, Mildner B, et al. Safety, tolerability and pharmacokinetics of PL 14736, a novel agent for treatment of ulcerative colitis, in healthy male volunteers. Gut 2003; 51: A309.
Ruenzi M, Stolte M, Veljaca M, Oreskovic K, Peterson J. A multicenter, randomized, double blind, placebo-controlled phase II study of PL 14736 enema in the treatment of mild-to-moderate ulcerative colitis. Gastroenterology 2005; 128: A584. — Preceding unsigned comment added by Bstard12 (talk • contribs) 22:06, 3 October 2017 (UTC)
- I deleted the "no human studies" part as it clearly has human studies, at least 2 of them published, one of them (IBS study) even mentioned in title of ref 2, and I want to stop the spread of this popular piece of misinformation. I or someone should later add a comment and ref to said studies (above).--Bstard12 (talk) 11:59, 10 February 2018 (UTC)
Categories:
- Stub-Class Molecular Biology articles
- Unknown-importance Molecular Biology articles
- Stub-Class MCB articles
- Low-importance MCB articles
- WikiProject Molecular and Cellular Biology articles
- All WikiProject Molecular Biology pages
- Stub-Class chemicals articles
- Low-importance chemicals articles
- Stub-Class AfC articles
- AfC submissions by date/16 August 2017
- Accepted AfC submissions